Galliford Try Holdings PLC (LSE:GFRD) announced its non-executive chairperson Peter Ventress will step down on 15 September after more than seven years on the board, to be replaced by Alison Wood.
“The board is extremely grateful to Peter for his contribution to and chairing of the board over the last seven years and during the group's transformation, in recent years, to its current position as one of the UK's leading construction groups,” Terry Miller, senior independent director, said.
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) has taken an important step towards gaining accreditation for a US lab that will help showcase the commercial potential of its Parsortix liquid biopsy system.
The Centers for Medicare and Medicaid Services (CMS) has issued a certificate of registration, the company said in a statement.
Sovereign Metals Ltd (ASX:SVM, AIM:SVML) has encountered the highest rutile grades to date in assay results from a 2021 drilling program at the flagship Kasiya-Nsaru Project in Malawi, increasing the drill-defined mineralised footprint by 28% to 165 square kilometres.
Sovereign has determined that the Kasiya and Nsaru deposits are a single, very large, coherent body of near-surface rutile and graphite mineralisation.
Chill Brands Group PLC clarified that the related party transaction referenced in its half-year report in January was not a cash transfer but rather an extended payment plan for the value of product shipped to Ox Distributing, its master distributor and a substantial shareholder.
Highlight Therapeutics, the clinical-stage biopharmaceutical company developing RNA-based therapies against cancer, today announced an oral presentation at the Combination Immunotherapy Clinical Trials Plenary Session at the American Association for Cancer Research annual meeting, taking place April 8-13, 2022 in New Orleans, Louisiana. The company will also present three posters.